Purchase Order 75N93025P00204
Award Date
3/1/25
Potential Completion Date
2/28/26
Potential Value
$73K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a renewal service agreement to support two Illumina NextSeq sequencing systems. The contract has a ceiling value of $74,756.41 and a period of performance through March 20, 2026. There is no set-aside designation for this award. Illumina is a manufacturer of genomic sequencing...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government, to Illumina, Inc. for a service agreement for a NextSeq 2000 sequencing system. The total ceiling value of the contract is $48,209.00 and it has an ultimate completion date of December 15, 2025. This contract does not have a set-aside designation. Illumina is a manufacturer of genomic sequencing instruments and reagents, and...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the U.S. Department of Health and Human Services, to Illumina, Inc. for a MiSeq and NextSeq maintenance service agreement. The contract has a ceiling value of $54,252.56 and a performance period ending on March 24, 2030. Illumina is a manufacturer of genetic sequencing systems and related consumables. The award does not utilize any small business set-asides....
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the basic product care maintenance of a NextSeq S/N NSS00515 sequencing system, including a 4-year service plan. The total ceiling value of the contract is $137,565.03. Illumina, a manufacturer of DNA sequencing instruments and reagents, has previously received other prime...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the maintenance of an Illumina MiSeq sequencer used for immunology and inflammation research. The contract has a ceiling value of $16,198.00 and a period of performance through May 26, 2026. Illumina, a leading manufacturer of genetic sequencing and genomic analysis technologies, has been...
This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for an annual service agreement to maintain NIAID's Illumina MiSeq and NextSeq 500 sequencing systems used to support ongoing research on influenza and respiratory diseases. The contract has a total ceiling value...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract, valued at $12,875.00, is for sequencing services to support NIAID's research and diagnostic efforts. Illumina has previously been awarded other prime federal contracts and subcontracts by...
This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc. for the procurement of Illumina NextSeq, NovaSeq, and Nextera sequencing systems and associated kits. The contract has a ceiling value of $44,228.22 and a period of performance through December 31, 2024. This order is not set aside for any special business categories. Illumina is an established provider of genomic sequencing instruments...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract provides a MiSeq Silver Support Plan with a ceiling value of $13,250.00 and an ultimate completion date of January 2, 2021. Illumina has a long history of providing sequencing systems and related products and services to support research and diagnostics across...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and consumables. The contract is for service and maintenance of an Illumina MiSeq system for fiscal year 2021, with a total ceiling value of $14,070.00. The contract has no set-aside designation. Illumina has received numerous prior federal...